BioInitials

About Us

BioInitials, incorporated in May 2019, develops non-invasive medical devices to monitor the health-state of the oral cavity. Our goal is to increase the degree of oral health among the general population, to prevent periodontitis, diabetes and cardiovascular diseases.

Periodontitis is a significant public health problem with prevalence higher than 50%. In the USA and Europe, the disease affects more than 220 million patients. The disease that affects 700 million patients worldwide, is correlated to Diabetes. Cardiovascular diseases are the number one cause of death globally, with a prevalence of 422 million patients and taking an estimated 18 million lives each year.

Development

Partners